Particle.news
Download on the App Store
4 ARTICLES
·
6d ago

Sandy Alcantara's Trade Value Stalls as Post-Surgery Struggles Continue

MLB executives hesitate to pursue the former Cy Young winner as his early 2025 performance raises concerns about his recovery and effectiveness.

Sandy Alcantara #22 of the Miami Marlins throws a pitch during the first inning against the Los Angeles Dodgers at Dodger Stadium on April 29, 2025 in Los Angeles.
Image
Image
Image

Overview

  • Sandy Alcantara, recovering from Tommy John surgery, has posted a 2-3 record with an 8.31 ERA and 1.654 WHIP through six starts in 2025.
  • His strikeout rate has dropped to 19.8%, while opponents are hitting harder and producing a .693 OPS against him, highlighting diminished pitch effectiveness.
  • MLB executives are reluctant to offer top prospects in trade discussions until Alcantara demonstrates clear signs of returning to his pre-injury form.
  • The Marlins, currently in last place in the NL East, may delay trading Alcantara in hopes of boosting his value closer to the July 31 trade deadline.
  • Alcantara's team-friendly $56 million contract and Cy Young pedigree make him a valuable asset if he can regain command and consistency.